Compare Humana Inc (HUM) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs ProShares UltraPro Short QQQ ETF — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while ProShares UltraPro Short QQQ ETF trades at $32.7 (market cap $2.12B). The key difference: Humana Inc is far larger — about 22.5× ProShares UltraPro Short QQQ ETF's market cap, and Humana Inc pays a 0.89% dividend while ProShares UltraPro Short QQQ ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and ProShares UltraPro Short QQQ ETF for 12 Days on average.
| HUM | SQQQ | |
|---|---|---|
Market Cap | $47.61B | $2.12B |
Volume | 1,827,332 | 42,185,633 |
Sector | Health | Leveraged / Inverse |
52-Week High | $409.85 | $89.43 |
52-Week Low | $163.67 | $31.83 |
Typical Hold Time | 53 Days | 12 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
SQQQ trades at $32.08, up 0.79% with a bearish technical signal from moving averages but bullish oscillators. The ETF shows oversold conditions with RSI readings below 20, suggesting potential for short-term rebound. Recent news highlights SQQQ's role as a hedging tool against Nasdaq 100 declines, with inverse ETFs potentially benefiting from tech sector weakness.
The outlook remains highly speculative given SQQQ's 3x leveraged inverse structure. While current technical indicators suggest potential for near-term recovery, the ETF faces significant decay risks in sustained bull markets. Investors should weigh hedging benefits against the structural challenges of leveraged inverse products in volatile conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
